BamSEC and AlphaSense Join Forces
Learn More

Allergan Finance LLC

Formerly NYSE: ACT
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.4M
from 10-Q 8 pages Actavis, Inc. the 2001 Incentive Award Plan Notice of Grant and Signature Page
12/34/56
EX-10.4L
from 10-Q 22 pages Actavis, Inc. the 2001 Incentive Award Plan Notice of Grant and Signature Page
12/34/56
EX-10.4K
from 10-Q 8 pages Actavis, Inc. 2001 Incentive Award Plan Notice of Grant and Signature Page
12/34/56
EX-10.2F
from 10-Q 20 pages Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Actavis, Inc
12/34/56
EX-10.4J
from 10-K 8 pages Actavis, Inc. 2001 Incentive Award Plan Notice of Grant and Signature Page
12/34/56
EX-10.4I
from 10-K 21 pages Actavis, Inc. the 2001 Incentive Award Plan Notice of Grant and Signature Page
12/34/56
EX-10.1
from 8-K 36 pages Watson Pharmaceuticals, Inc. Amended and Restated Key Employee Agreement
12/34/56
EX-10.28
from 10-Q 1 page Amendment to Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc
12/34/56
EX-10.26
from 10-Q 50 pages Supply Agreement
12/34/56
EX-10.25
from 10-Q 35 pages Confidential Portions of This Exhibit Marked as [**] Have Been Omitted Pursuant to a Request for Confidentiality and Filed Separately With the Securities and Exchange Commission. U.S. Supply and Distribution Agreement
12/34/56
EX-10.1
from 8-K 29 pages Project Compass Commitment Letter
12/34/56
EX-10.23B
from 10-K 1 page February 10, 2012 Watson Pharmaceuticals, Inc. (On Behalf of Coventry Acquisition, LLC) 311 Bonnie Circle Corona, Ca 92880 Attention: David A. Buchen, Executive Vice President, General Counsel, and Secretary Re: Second Closing Under the March 3, 2010 Purchase and Collaboration Agreement Dear Mr. Buchen: /S/ David A. Buchen Accepted and Agreed to by Watson Pharmaceuticals, Inc. (On Behalf of Coventry Acquisition, LLC) CC Latham & Watkins Llp Attention: R. Scott Shean
12/34/56
EX-10.2
from 10-K 26 pages Third Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc
12/34/56
EX-10.2
from 10-Q 6 pages Watson Pharmaceuticals, Inc., as Issuer and Wells Fargo Bank, National Association, as Trustee Second Supplemental Indenture Dated as of May 7, 2010 to the Indenture Dated as of August 24, 2009 5.000% Senior Notes Due 2014 6.125% Senior Notes Due 2019
12/34/56
EX-10.1
from 10-Q 3 pages Consulting Agreement
12/34/56
EX-10.1
from 10-Q 1 page Second Amendment to Key Employee Agreement
12/34/56
EX-10.1
from 8-K 17 pages Watson Pharmaceuticals, Inc. Key Employee Agreement
12/34/56
EX-10.1
from 8-K 1 page Second Amendment to Key Employee Agreement
12/34/56
EX-10.27
from 10-K 2 pages Amendment to Key Employee Agreement
12/34/56
EX-10.9
from 10-K 3 pages Amendment to Key Employee Agreement
12/34/56